These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2351822
1. Concerning the sensitivity of Acinetobacter calcoaceticus. Jedlicková Z, Tesaríková E, Výmola F. J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822 [Abstract] [Full Text] [Related]
2. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup. Capoor MR, Nair D, Srivastava L, Gupta B, Aggarwal P. J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272 [Abstract] [Full Text] [Related]
3. [Sensitivity of bacteria of the genus Acinetobacter to antibiotics and ofloxacin]. Fleischer M, Przondo-Mordarska A, Ruczkowska J. Med Dosw Mikrobiol; 1991 Jun; 43(3-4):103-10. PubMed ID: 1823372 [Abstract] [Full Text] [Related]
4. [In vitro effect of antibiotics against hospital strains of Acinetobacter baumanii]. Hercouet H, Bousser J, Donnio PY, Avril JL. Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):612-6. PubMed ID: 2797884 [Abstract] [Full Text] [Related]
5. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776]. Joly-Guillou ML, Serieys C, Verin-Prevost C, Bergogne-Berezin E. Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329 [Abstract] [Full Text] [Related]
6. [Antibacterial activity of aminoglycosides against nosocomial strains of Acinetobacter baumannii isolated between 1990 and 1999]. González G, Ramírez C, Muñoz M. Rev Esp Quimioter; 2000 Dec; 13(4):401-4. PubMed ID: 11498707 [Abstract] [Full Text] [Related]
7. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J. Clin Infect Dis; 2001 May 15; 32 Suppl 2():S104-13. PubMed ID: 11320451 [Abstract] [Full Text] [Related]
8. [Problem of treatment for pyo-inflammatory complications caused by Acinetobacter]. Bogomolova NS, Bol'shakov LV, Kuznetsova SM. Anesteziol Reanimatol; 2014 May 15; (1):26-32. PubMed ID: 24749305 [Abstract] [Full Text] [Related]
9. [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus]. Joly-Guillou ML, Bergogne-Bérézin E. Pathol Biol (Paris); 1986 Jun 15; 34(5 Pt 2):625-8. PubMed ID: 3534756 [Abstract] [Full Text] [Related]
13. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. Deris ZZ, Harun A, Shafei MN, Rahman RA, Johari MR. Southeast Asian J Trop Med Public Health; 2009 Jan 15; 40(1):140-7. PubMed ID: 19323046 [Abstract] [Full Text] [Related]
18. [Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca]. Nejjari N, Zerhouni F, Bouharrou A, Habzi A, Najdi T, Lahbabi M, Benomar S. Tunis Med; 2003 Feb 15; 81(2):121-5. PubMed ID: 12708178 [Abstract] [Full Text] [Related]